已收盤 10-31 16:00:00 美东时间
+0.560
+0.87%
Halozyme Therapeutics (NASDAQ:HALO) will release its quarterly earnings report ...
11-01 02:02
High-performance, low-pressure gas filters will ensure safe delivery of oxygen ...
10-28 21:30
今日重点评级关注:Guggenheim:上调Neumora Therapeutics评级至"买入",目标价14美元;韦德布什:上调Fate Therapeutics评级至"跑赢大市",目标价从5美元升至7美元
10-28 10:08
JP Morgan analyst Jessica Fye maintains Halozyme Therapeutics (NASDAQ:HALO) with a Neutral and raises the price target from $63 to $65.
10-27 22:19
今日重点评级关注:Maxim Group:维持Rani Therapeutics Hldgs"买入"评级,目标价从5美元升至10美元;韦德布什:维持Corbus Pharmaceuticals"跑赢大市"评级,目标价从31美元升至38美元
10-21 18:13
今日重点评级关注:Roth Capital:维持Cingulate"买入"评级,目标价从10美元升至17美元;JMP证券:维持BioCryst Pharma"跑赢大市"评级,目标价从17美元升至27美元
10-16 10:43
Halozyme Therapeutics (NASDAQ:HALO) has been analyzed by 10 analysts in the las...
10-16 04:01
今日重点评级关注:摩根士丹利:上调Alvotech评级至"超配",目标价14美元;蒙特利尔银行:维持PG&E"跑赢大市"评级,目标价从23美元升至25美元
10-15 18:20
Leerink Partners analyst David Risinger upgrades Halozyme Therapeutics (NASDAQ:HALO) from Underperform to Market Perform and announces $70 price target.
10-15 02:22
(来源:药剂Talks) “人生的光荣,不在于永不言败,而在于能够屡扑屡起。”辉瑞的减肥药征程,正是拿破仑这句名言的真实写照。 即使有三款GLP-1管线接连失...
10-10 14:10